Can thinking and walking at the same time predict falls in cancer survivors?

NCT ID NCT06313359

Recruiting now Knowledge-focused Sponsor: Texas Woman's University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at how nerve damage from cancer treatment affects a person's risk of falling and their quality of life. Researchers will test balance, thinking, and the ability to do two things at once (like walking while texting) in 40 adults with chemotherapy-related peripheral neuropathy. The goal is to understand which factors most strongly predict falls, so better prevention programs can be developed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help identify key factors that increase fall risk in cancer survivors, leading to better fall prevention strategies.
What could go wrong: This is a small observational study (40 participants) that measures associations, not a treatment trial. Results may not apply to all cancer survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chemotherapy-induced neuropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY

Contacts and locations

Locations

Texas Woman's University
RECRUITING

Dallas, Texas, 75235, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.